News & Updates

A decrease in arterial stiffness by means of antihypertensive treatment could pave the way of blood pressure (BP) reduction, a study has shown.

The Micra Transcatheter Pacing System (M-TPS) can be a safe and effective substitute to a conventional pacemaker, suggests a study presented at the recent EHRA 2023. M-TPS has a surgically created subcutaneous pocket and no transvenous leads, which help prevent complications.

Extended ECG monitoring for 30 days significantly increases the detection rates of arrhythmias compared with the standard 24-hour monitoring period in patients with hypertrophic cardiomyopathy (HCM), according to the TEMPO-HCM study presented at EHRA 2023.

Treatment with dapagliflozin leads to lower incidence of total heart failure (HF) events and cardiovascular death, regardless of patient characteristics such as ejection fraction, according to a study.

Individuals with atrial high-rates episodes (AHREs) are at greater risk of progression to atrial fibrillation (AF). But the good news is that treatment with antiarrhythmic medication appears to have a protective effect both on AHRE burden and AF risk.

Individuals who were born preterm and large for gestational age are at increased risk of atrial fibrillation (AF) up to middle age, and the risk increase is independent of familial confounding factors, according to a multinational cohort study.